{"id":13329,"date":"2021-05-24T17:44:44","date_gmt":"2021-05-24T15:44:44","guid":{"rendered":"https:\/\/porib.com\/?p=13329"},"modified":"2021-05-24T17:47:13","modified_gmt":"2021-05-24T15:47:13","slug":"tofacitinib-podria-ser-un-tratamiento-dominante-en-colitis-ulcerosa","status":"publish","type":"post","link":"https:\/\/porib.com\/en\/tofacitinib-podria-ser-un-tratamiento-dominante-en-colitis-ulcerosa\/","title":{"rendered":"Tofacitinib podr\u00eda ser un tratamiento dominante en colitis ulcerosa"},"content":{"rendered":"<p style=\"text-align: justify;\">Desde la perspectiva del Sistema Nacional de Salud, tofacitinib podr\u00eda ser un tratamiento coste-efectivo e incluso dominante (con menor coste y mayor efectividad) en comparaci\u00f3n con vedolizumab, con ahorros de costes relevantes y ganancias en a\u00f1os de vida ganados ajustados por calidad (AVAC) similares, seg\u00fan se desprende de la publicaci\u00f3n <strong><em>Cost-Effectiveness Analysis of Using Innovative Therapies for the Management of Moderate-To-Severe Ulcerative Colitis in Spain.<\/em><\/strong><\/p>\n<div class=\"col80p\">\n<p style=\"text-align: justify;\">El art\u00edculo de los autores Taxonera C, de Andr\u00e9s-Nogales F, Garc\u00eda-L\u00f3pez S, S\u00e1nchez-Guerrero A, Mench\u00e9n B, Peral C, C\u00e1bez A, G\u00f3mez S, L\u00f3pez-Ib\u00e1\u00f1ez de Aldecoa A, Casado MA, Mench\u00e9n L, que ha sido publicado en la revista <em>Expert Review of Pharmacoeconomics &amp; Outcomes Research<\/em>, ten\u00eda como objetivo evaluar la eficiencia de tofacitinib, en comparaci\u00f3n con vedolizumab, para el tratamiento de pacientes adultos con colitis ulcerosa moderada a grave que han tenido una respuesta insuficiente, una p\u00e9rdida de respuesta o han sido intolerantes al tratamiento convencional o a un medicamento biol\u00f3gico de primera l\u00ednea.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Desde la perspectiva del Sistema Nacional de Salud, tofacitinib podr\u00eda ser un tratamiento coste-efectivo e incluso dominante (con menor coste y mayor efectividad) en comparaci\u00f3n con vedolizumab, con ahorros de costes relevantes y ganancias en a\u00f1os de vida ganados ajustados por calidad (AVAC) similares, seg\u00fan se desprende de la publicaci\u00f3n Cost-Effectiveness Analysis of Using Innovative&#8230; <\/p>\n<div class=\"clear\"><\/div>\n<p><a href=\"https:\/\/porib.com\/en\/tofacitinib-podria-ser-un-tratamiento-dominante-en-colitis-ulcerosa\/\" class=\"excerpt-read-more\">Read More<i class=\"fa fa-caret-right icon-caret-right\"><\/i><\/a><\/p>\n","protected":false},"author":1,"featured_media":13331,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[67],"tags":[],"class_list":["post-13329","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ultimas-noticias"],"translation":{"provider":"WPGlobus","version":"2.10.3","language":"en","enabled_languages":["es","en"],"languages":{"es":{"title":true,"content":true,"excerpt":false},"en":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13329"}],"collection":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/comments?post=13329"}],"version-history":[{"count":1,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13329\/revisions"}],"predecessor-version":[{"id":13330,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/posts\/13329\/revisions\/13330"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media\/13331"}],"wp:attachment":[{"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/media?parent=13329"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/categories?post=13329"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/porib.com\/en\/wp-json\/wp\/v2\/tags?post=13329"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}